Cell Washers Market Size & Share 2024 – 2032

Cell Washers Market Size

Cell Washers Market size was valued at around USD 257.9 million in 2023 and is estimated to grow at 4.8% CAGR from 2024 to 2032. Cell washers are laboratory instruments used to wash cells or cellular components gently while preserving their integrity and viability. They are crucial in procedures such as blood banking, immunology, and cell culture.

Increasing prevalence of chronic diseases such as anemia, cancer, hemophilia, and sickle cell disease is boosting demand for cell washers. For instance, as per data from the Centers for Disease Control and Prevention, in the U.S. alone, there are between 30,000 and 33,000 individuals dealing with hemophilia. Hemophilia A impacts around 1 in every 5,617 male births, while hemophilia B affects roughly 1 in every 19,283 male births in the U.S. Advanced therapies such as stem cell transplants and blood transfusions are crucial, with cell washers playing a vital role in preparing blood components accurately.
 

These devices ensure the purity and integrity of blood cells, essential for successful outcomes in treatments. Thus, as healthcare facilities prioritize the adoption of advanced technologies to meet the rising demand for hematologic disorder treatments, the market for cell washers experiences significant growth.
 

Furthermore, the rising need for blood transfusions is being driven by a variety of medical procedures and treatments. Surgeries, especially those dealing with significant trauma, organ transplants, and cancer therapies, often necessitate blood transfusions to replace lost blood and stabilize patients. Cell washers are vital in maintaining the quality and viability of blood and blood components used in transfusions by eliminating impurities and preserving cell health. Hence, the increasing demand for blood transfusions directly correlates with the heightened requirement for cell washers in medical environments.
 

Cell Washers Market Trends

• Advancements in efficiency, reliability, and ease of use have propelled significant growth in the market. Integration of automation and robotics enhances throughput and reduces errors, while tailored washing protocols ensure cell viability. Features such as closed-system designs and sterilization mechanisms minimize contamination risks.
   
• Fresenius SE & Co. KGaA's LOVO Automated Cell Processing System exemplifies this progress, revolutionizing the washing and concentration of white blood cell products.
   
• Thus, ongoing innovation in cell washer technology not only meets the needs of research and clinical environments but also fosters advancements in fields such as cell biology and regenerative medicine.
   

Cell Washers Market Analysis

Based on product, the market is divided into equipment, and consumables. The consumables segment is further bifurcated into single-use and reusable. The consumables segment of the market is forecasted to reach USD 211.3 million by 2032, displaying robust growth propelled by several key factors.
 

• The surge in adoption of cell washing techniques across diverse biomedical and clinical research domains is fueling the need for associated consumables. Essential for numerous laboratory protocols such as cell culture, cell-based assays, and flow cytometry which is estimated to reach USD 11.2 billion by 2032, cell washing has become indispensable.
   
• With ongoing advancements and expansion in biotechnology, pharmaceuticals, and life sciences research, the demand for consumables specific to cell washing is anticipated to escalate correspondingly.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end-use, the cell washers market is bifurcated into diagnostic laboratories, and blood banks and transfusion centers, and other end-users. The diagnostic laboratories segment accounted for USD 116.3 million in 2023.
 

• With the expansion of healthcare infrastructure, spurred by the establishment of laboratories in hospitals and clinics, the demand for cell washers is increasing to support medical procedures and research. The growing number of diagnostic labs underscores the heightened need for advanced medical equipment, including cell washers, to improve patient care and diagnostics.
   
• Additionally, diagnostic labs are increasingly prioritizing research and development efforts to advance medical science and enhance patient outcomes, with cell washers serving a crucial role in isolating and studying various cell types for drug discovery, regenerative medicine, and personalized therapy purposes.
   
• Thus, the diagnostic laboratories segment is expected to experience robust growth in the market due to these factors.
   

The U.S. cell washer market is forecasted to reach USD 116.5 million by 2032, driven by growing demand for advanced medical equipment due to increased surgical procedures, especially in orthopedics, cardiology, and oncology.
 

• The rising number of cancer diagnoses, projected at over 1.9 million by the American Cancer Society in 2023, creates a significant need for blood during chemotherapy. Moreover, the continuous demand for blood and blood platelets, with someone needing them every 2 seconds according to the American Red Cross, results in approximately 16 million blood components being transfused annually.
   
• Therefore, the escalating demand for blood products fuels the use of cell washers, crucial for maintaining the cleanliness and integrity of blood and cell components used in transfusions and medical treatments.
   

The cell washers market in UK is expected to experience significant and promising growth from 2024 to 2032.

• The UK's significant allocation of healthcare expenditure towards advanced medical equipment, coupled with the national health service (NHS) emphasis on technological innovation, drives the adoption of cell washers across hospitals and research institutions. These instruments play a pivotal role not only in blood transfusion but also in supporting critical areas such as stem cell research and cell therapy.
   
• Additionally, the burgeoning interest in cell-based therapies and regenerative medicine amplifies the demand for technologies enabling cellular processing and manipulation.
   

Japan market is anticipated to witness lucrative growth between 2024 – 2032.
 

• Japan's pharmaceutical and biotechnology industries are expanding rapidly, driven by factors such as an aging population, increasing healthcare expenditure, and government initiatives to promote innovation in the life sciences sector.
   
• Therefore, as these industries continue to grow, there will be a corresponding increase in the demand for cell washers for drug discovery, development, and production processes.
   

The cell washers market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
 

• Saudi Arabia has been heavily investing in its healthcare infrastructure to meet the demands of its growing population. Therefore, as the healthcare sector expands, there is a corresponding increase in the demand for medical equipment, including cell washers, to support research and diagnostic activities.
   

Cell Washers Market Share

The cell washers sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.
 

Cell Washers Market Companies

Some of the eminent market participants operating in the cell washers industry include:

• Andreas Hettich GmbH & Co. KG
• Bio-Rad Laboratories, Inc.
• Centurion Scientific
• Changsha Yingtai Instrument Co., Ltd.
• Corning Incorporated
• CYTENA GmbH
• Danaher Corporation
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• Helmer Scientific Inc.
• Labtron Equipment Ltd.
• LivaNova PLC
• Labozon Scientific Inc.
• Medfuture Biotech Co., Ltd.
• Terumo Corporation
   

Cell Washers Industry News:

• In March 2023, Haemonetics Corporation obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its latest software iteration designed for the Cell Saver Elite+ Autotransfusion System. The newly launched software, Intelligent Control, brought significant improvements aimed at streamlining operations, thereby enhancing efficiency and user satisfaction. With this regulatory approval, Haemonetics gained a strategic advantage in the market, poised to drive increased revenue for the company.
   
• In May 2023, Trane Technologies, a pioneer in global climate innovation, completed the acquisition of Helmer Scientific, a renowned leader in providing precision temperature-controlled storage and processing solutions for hospitals, laboratories, blood banks, and pharmacies. With this acquisition, Trane Technologies planned to utilize its top-tier operating system and expertise in sustainability, services, global distribution, and commercialization to propel Helmer's ongoing global expansion efforts.
   

The cell washers market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million and volume in Units from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Equipment
  • Automated
  • Manual
• Consumables
  • Single-use
  • Reusable

Market, By End-use

• Diagnostic laboratories
• Blood banks and transfusion centers
• Other end-users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europ 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America 
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa